Edesa Biotech, Inc. Common Shares (EDSA) is a publicly traded Healthcare sector company. As of October 15, 2026, EDSA trades at $2.74 with a market cap of $27.43M and a P/E ratio of -3.04. EDSA moved +0.75% today. Year to date, EDSA is +76.67%; over the trailing twelve months it is +5.58%. Its 52-week range spans $0.72 to $20.32. Rallies surfaces EDSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for EDSA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.74 |
| Market Cap | $27.43M |
| P/E Ratio | -3.04 |
| EPS | $-1.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.32 |
| 52-Week Low | $0.72 |
| Volume | 29.02K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.19M |
| Gross Margin | 0.00% |
EDSA analyst coverage data. Average price target: $0.00.